Previous studies have demonstrated that α-MT administration or TH gene inactivation can enhance the locomotor therapeutic effects of DA receptor agonists in mice PD models, suggesting the feasibility of our proposed combination therapy with α-MT and DA receptor agonists for PD [108,109]. This evidence concerns the gene MCAT and Parkinson disease.